-transparent.png){kind=logo}
Immunoperoxidase staining for carcinoembryonic antigen (CEA) was performed on the tumors of 241 patients with invasive carcinoma of the cervix. Positive tissue staining indicative of a CEA concentration of at least 3 microgram/gm was present in 154 tumors (63%) as opposed to 0 of 30 specimens of normal cervix (p less than .001). Plasma CEA values were obtained at the time of tissue staining on all patients. Plasma CEA concentration was related more directly to total tumor burden (tumor CEA content x extent of disease) than to tumor CEA concentration alone. Progressively rising plasma CEA levels predicted recurrent disease in over 80% of patients whose tumors stained positively for CEA. In contrast, serial plasma CEA values correlated positively with clinical disease status in only 28% of patients whose tumors were devoid of CEA. Immunoperoxidase staining of tissue specimens identifies those patients whose tumors contain high levels of CEA and who therefore should benefit most from subsequent plasma antigen determinations.
J R van Nagell, and
E S Donaldson, and
E C Gay, and
S Hudson, and
R M Sharkey, and
F J Primus, and
D F Powell, and
D M Goldenberg
January 1979,
Bulletin du cancer,
J R van Nagell, and
E S Donaldson, and
E C Gay, and
S Hudson, and
R M Sharkey, and
F J Primus, and
D F Powell, and
D M Goldenberg
December 1977,
Gynecologic oncology,
J R van Nagell, and
E S Donaldson, and
E C Gay, and
S Hudson, and
R M Sharkey, and
F J Primus, and
D F Powell, and
D M Goldenberg
September 1981,
Journal of the National Cancer Institute,
J R van Nagell, and
E S Donaldson, and
E C Gay, and
S Hudson, and
R M Sharkey, and
F J Primus, and
D F Powell, and
D M Goldenberg
January 2006,
European journal of gynaecological oncology,
J R van Nagell, and
E S Donaldson, and
E C Gay, and
S Hudson, and
R M Sharkey, and
F J Primus, and
D F Powell, and
D M Goldenberg
January 1986,
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine,
J R van Nagell, and
E S Donaldson, and
E C Gay, and
S Hudson, and
R M Sharkey, and
F J Primus, and
D F Powell, and
D M Goldenberg
September 1991,
The Tohoku journal of experimental medicine,
J R van Nagell, and
E S Donaldson, and
E C Gay, and
S Hudson, and
R M Sharkey, and
F J Primus, and
D F Powell, and
D M Goldenberg
September 1976,
American journal of obstetrics and gynecology,
J R van Nagell, and
E S Donaldson, and
E C Gay, and
S Hudson, and
R M Sharkey, and
F J Primus, and
D F Powell, and
D M Goldenberg
June 1976,
Gynecologic oncology,
J R van Nagell, and
E S Donaldson, and
E C Gay, and
S Hudson, and
R M Sharkey, and
F J Primus, and
D F Powell, and
D M Goldenberg
March 1997,
Gynecologic oncology,
J R van Nagell, and
E S Donaldson, and
E C Gay, and
S Hudson, and
R M Sharkey, and
F J Primus, and
D F Powell, and
D M Goldenberg
April 1989,
Obstetrics and gynecology,
